Ultragenyx Pharmaceutical Inc. Insider Trading for November 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for November 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18 2016 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | Controller and PAO | Option Exercise | M | 21.00 | 2,000 | 42,000 | 22,403 | |
| Nov 18 2016 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | Controller and PAO | Sell | S | 79.73 | 2,000 | 159,460 | 11,134 | 13.1 K to 11.1 K (-15.23 %) |
| Nov 18 2016 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | Controller and PAO | Buy | M | 21.00 | 2,000 | 42,000 | 13,134 | 11.1 K to 13.1 K (+17.96 %) |
| Nov 17 2016 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 83.01 | 200 | 16,602 | 447,147 | 447.3 K to 447.1 K (-0.04 %) |
| Nov 17 2016 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 82.36 | 4,180 | 344,265 | 447,347 | 451.5 K to 447.3 K (-0.93 %) |
| Nov 17 2016 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 81.55 | 7,755 | 632,420 | 451,527 | 459.3 K to 451.5 K (-1.69 %) |
| Nov 17 2016 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 80.64 | 6,451 | 520,209 | 459,282 | 465.7 K to 459.3 K (-1.39 %) |
| Nov 17 2016 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 79.39 | 1,414 | 112,257 | 465,733 | 467.1 K to 465.7 K (-0.30 %) |
| Nov 10 2016 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Option Exercise | M | 0.82 | 24,000 | 19,560 | 62,663 | |
| Nov 10 2016 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 74.34 | 700 | 52,038 | 45,387 | 46.1 K to 45.4 K (-1.52 %) |
| Nov 10 2016 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 73.65 | 2,600 | 191,490 | 46,087 | 48.7 K to 46.1 K (-5.34 %) |
| Nov 10 2016 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 72.81 | 3,205 | 233,356 | 48,687 | 51.9 K to 48.7 K (-6.18 %) |
| Nov 10 2016 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 71.68 | 3,895 | 279,194 | 51,892 | 55.8 K to 51.9 K (-6.98 %) |
| Nov 10 2016 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 70.06 | 13,600 | 952,816 | 55,787 | 69.4 K to 55.8 K (-19.60 %) |
| Nov 10 2016 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Buy | M | 0.82 | 24,000 | 19,560 | 69,387 | 45.4 K to 69.4 K (+52.88 %) |